Ovarian cancer occurs when there is an uncontrolled growth of abnormal cells in the ovaries or fallopian tubes. This is one ...
By Deena Beasley June 3 (Reuters) - Cathy Smithwick, now 67, has lived with breast cancer, and then ovarian cancer, for more ...
Adding chiauranib to weekly paclitaxel improves PFS, but not OS, in patients with platinum-resistant or refractory ovarian cancer.
German biotech Tubulis has shared updated data from a phase 1 study of the antibody-drug conjugate (ADC) TUB-040, the star behind Gilead’s decision to buy the company for $3.15 billion upfront in A | ...
High-volume hospitals with frequent NACT use had the lowest 90-day surgical mortality and longest 60-month survival. NACT reduced perioperative deaths in all hospital types, including those with low ...
Combing data collected on thousands of California ovarian cancer patients, UC Davis researchers have determined that almost one-third survived at least 10 years after diagnosis. The unprecedented ...
BioInvent International AB (publ) ( BOVNF) Discusses Ovarian Cancer Treatment Landscape and TNFR2-Targeted Therapies in Solid Tumors May 27, 2026 8:00 AM EDT Good morning, and welcome to the BioInvent ...
Rising ovarian and uterine cancer rates are linked to high BMI, with disparities across sociodemographic index levels, particularly in low- and middle-SDI regions. Sarcopenia is prevalent in ...